198 related articles for article (PubMed ID: 27192524)
21. [Extra-nodal NK/T-cell lymphoma, nasal-type, revealed by cutaneous and ocular involvement].
Marzouki-Zerouali A; Charbit L; Mitcov M; Violon F; Schmutz JL; Moawad S; Bursztejn AC
Ann Dermatol Venereol; 2019 Oct; 146(10):626-633. PubMed ID: 31371036
[TBL] [Abstract][Full Text] [Related]
22. [Long-term survival after nasal NK/T cell lymphoma].
Rajnics P; Krenács L; Kenéz A; Járay Z; Bagdi E; Demeter J
Orv Hetil; 2008 Apr; 149(17):801-5. PubMed ID: 18426762
[TBL] [Abstract][Full Text] [Related]
23. CD56-negative extranodal nasal type NK/T-cell lymphoma.
Miles RR; Afify Z; Yaish H; Perkins SL
Pediatr Blood Cancer; 2010 Jul; 55(1):186-9. PubMed ID: 20486184
[TBL] [Abstract][Full Text] [Related]
24. Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.
Xu J; Xu X; Chen J; Wang J; Jiang C; Lv C; Chen B
Medicine (Baltimore); 2021 Mar; 100(10):e24824. PubMed ID: 33725836
[TBL] [Abstract][Full Text] [Related]
25. [Expression and significance of p53-related proteins and LMP-1 in nasal NK/T-cell lymphoma].
Xu G; Wang HF; He G; Xie K
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):351-5. PubMed ID: 19799083
[TBL] [Abstract][Full Text] [Related]
26. Late diagnosis: a case of rapidly progressive extranodal NK/T cell lymphoma, nasal type.
Mori H; Ebisawa K; Nishimura M; Kanazawa K
BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29455176
[TBL] [Abstract][Full Text] [Related]
27. CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
Lee WJ; Moon IJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
Int J Dermatol; 2019 Jun; 58(6):688-696. PubMed ID: 30597548
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant extranodal NK/T-cell lymphoma, nasal type with cutaneous and pulmonary involvement.
Acosta AM; Alagiozian-Angelova V; Kovarik P; Sekosan M
Pathology; 2016 Jun; 48(4):380-3. PubMed ID: 27130835
[No Abstract] [Full Text] [Related]
29. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
Wang B; Li XQ; Ma X; Hong X; Lu H; Guo Y
Am J Hematol; 2008 Oct; 83(10):795-9. PubMed ID: 18756548
[TBL] [Abstract][Full Text] [Related]
31. Intravascular NK/T-cell lymphoma: a report of five cases with cutaneous manifestation from China.
Wang L; Chen S; Ma H; Shi D; Huang C; Lu C; Gao T; Wang G
J Cutan Pathol; 2015 Sep; 42(9):610-7. PubMed ID: 25931234
[TBL] [Abstract][Full Text] [Related]
32. Pediatric nasal NK/T-cell lymphoma microscopically mimicking carcinoma.
Sánchez-Romero C; Paes de Almeida O; Díaz Molina JP; Carlos R
Int J Dermatol; 2020 Mar; 59(3):373-376. PubMed ID: 31729756
[No Abstract] [Full Text] [Related]
33. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.
Bekkenk MW; Vermeer MH; Geerts ML; Noordijk EM; Heule F; van Voorst Vader PC; van Vloten WA; Meijer CJ; Willemze R
J Clin Oncol; 1999 Aug; 17(8):2471-8. PubMed ID: 10561311
[TBL] [Abstract][Full Text] [Related]
34. [Nasal NK/T-cell lymphoma: about two rare cases].
Bouayad N; Oubelkacem N; Bono W; Masbah O; Bouhafa T; Elmazghi A; Khalid H
Pan Afr Med J; 2018; 30():141. PubMed ID: 30374387
[TBL] [Abstract][Full Text] [Related]
35. Case of extranodal natural killer/T-cell lymphoma, nasal type, accompanied by Epstein-Barr virus-positive nasopharyngeal carcinoma.
Senda N; Miyagaki T; Oka T; Itoigawa A; Kikuchi K; Kobayashi T; Nakamura F; Kurokawa M; Sugaya M; Sato S
J Dermatol; 2019 May; 46(5):e161-e163. PubMed ID: 30379350
[No Abstract] [Full Text] [Related]
36. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
37. PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.
Zheng W; Gao Y; Ke X; Zhang W; Su L; Ren H; Lin N; Xie Y; Tu M; Liu W; Ping L; Ying Z; Zhang C; Deng L; Wang X; Song Y; Zhu J
BMC Cancer; 2018 Sep; 18(1):910. PubMed ID: 30241515
[TBL] [Abstract][Full Text] [Related]
38. A case of primary cutaneous extranodal natural killer/t-cell lymphoma, nasal type, with a 22-year indolent clinical course.
Zuriel D; Fink-Puches R; Cerroni L
Am J Dermatopathol; 2012 Apr; 34(2):194-7. PubMed ID: 22172956
[TBL] [Abstract][Full Text] [Related]
39. Retrospective study of modified SMILE chemotherapy for advanced-stage, relapsed, or refractory extranodal natural killer (NK)/T cell lymphoma, nasal type.
Yang L; Liu H; Xu XH; Wang XF; Huang HM; Shi WY; Jiang SH
Med Oncol; 2013 Dec; 30(4):720. PubMed ID: 24062259
[TBL] [Abstract][Full Text] [Related]
40. Conjunctival extranodal natural killer/T-cell lymphoma, nasal type.
Kiratli H; Uzun S; Yeşilirmak A; Ayhan AS; Soylemezoğlu F
Cornea; 2015 Jun; 34(6):710-2. PubMed ID: 25811726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
